Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Shedding A Little Light On Under-Followed DUSA PharmaceuticalsStephen Simpson • Mon, Apr 16, 2012 -
DUSA Pharmaceuticals, Up 25% Tuesday, Still Has Room To RunAnalytical Chemist • Wed, Mar 7, 2012 -
-
-
-
-
-
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
6 Highly Profitable Healthcare Stocks With Plenty Of CashZetaKap • Fri, Aug 3, 2012
-
-
-
-
-
Top 10 Stocks With Strong Balance Sheet And Price Performance In 2012StockPandit • Fri, Apr 27, 2012 -
5 Undervalued Healthcare Stocks With Positive Receivables TrendsKapitall • Thu, Apr 12, 2012
-
-
Potential Trades For The Week Of Jan. 30: Looking For ConsolidationMichael Kudrna • Tue, Jan 31, 2012 -
-
-
-
-
-
52 Stocks Worth Watching That Hit 52 Week Highs Last FridayScott's Investments • Mon, Apr 4, 2011 -
31 Stocks Worth Watching That Hit 52 Week Highs on FridayScott's Investments • Mon, Mar 28, 2011
-
-
DUSA's CEO Discusses Q2 2012 Results - Earnings Call TranscriptThu, Aug 2, 2012
-
at MarketWatch.com (Nov 8, 2012)
-
at CNBC.com (Nov 8, 2012)
-
GlobeNewswire (Nov 8, 2012)
-
GlobeNewswire (Sep 13, 2012)
-
GlobeNewswire (Sep 4, 2012)
-
GlobeNewswire (Aug 2, 2012)
-
GlobeNewswire (Jun 15, 2012)
-
GlobeNewswire (Jun 7, 2012)
-
GlobeNewswire (May 31, 2012)
-
GlobeNewswire (May 8, 2012)
-
GlobeNewswire (Apr 24, 2012)
-
GlobeNewswire (Apr 10, 2012)
-
GlobeNewswire (Mar 23, 2012)
-
GlobeNewswire (Mar 19, 2012)
-
at MarketWatch.com (Mar 6, 2012)
DUSA vs. ETF Alternatives
Company Description
DUSA is a vertically integrated dermatology company that is developing and marketing Levulan PDT and other products for common skin conditions. We operate in two segments, Photodynamic Therapy, or PDT, Drug and Device Products and Non-Photodynamic Therapy, or Non-PDT, Drug Products. Our Levulan®... More
